HIGHLIGHTS
- who: David Stacey and colleagues from the MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge , RN, UK, Pfizer Worldwide Research and Development, Genome Sciences and Technologies, Cambridge, MA, USA, Pfizer Worldwide Research and Development, Inflammation and Immunology, Berlin, Germany, Department of Clinical Neurosciences, University of Cambridge, Cambridge , QQ, UK and , Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, PO, Doha, Qatar have published the article: ProGeM: a framework for the prioritization of candidate causal genes at molecular quantitative trait loci, in the Journal: (JOURNAL)
- what: The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.